HDAC inhibition involves CD26 induction on multiple myeloma cells via the c-Myc/Sp1-mediated promoter activation and overcomes therapeutic resistance by humanized antibody.
HDAC inhibition involves CD26 induction on multiple myeloma cells via the c-Myc/Sp1-mediated promoter activation and overcomes therapeutic resistance by humanized antibody.
复制标题
HDAC 抑制涉及通过 c-Myc/Sp1 介导的启动子激活对多发性骨髓瘤细胞进行 CD26 诱导，并克服人源化抗体的治疗耐药性。
DOI：
--
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Michiie Sakamoto
中科院分区：
文献类型：
--
作者：
Hiroko Nishida;Reiko Suzuki;Kiyora Nakajima;Mutsumi Hayashi;Michiie Sakamoto
